File manager - Edit - /home/cipherteam/htdocs/cipherteam.in/API/Finance/CompanyResults/dist/html/322479.html
Back
<div class="single_page_content"> <p align="justify">Suven Pharmaceuticals Limited has reported Consolidated financial results for the period ended September 30, 2022.<br><br><b>Financial Results (Q2 FY2023) - QoQ Comparison </b><br><br>The company has reported total income of Rs. 289.3218 crores during the period ended September 30, 2022 as compared to Rs. 349.8322 crores during the period ended June 30, 2022.<br><br>The company has posted net profit / (loss) of Rs. 72.0563 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 107.5421 crores for the period ended June 30, 2022.<br><br>The company has reported EPS of Rs. 2.83 for the period ended September 30, 2022 as compared to Rs. 4.22 for the period ended June 30, 2022.<br><br><table width="100%" border="2" bordercolor="#789940" cellspacing="0" cellpadding="0"> <tr> <td class="newsheader"><b>Financials</b></td> <td class="newsheader"><b>Q2 FY2023</b></td> <td class="newsheader"><b>Q1 FY2023</b></td> <td class="newsheader"><b>% Change</b></td> </tr> <tr> <td><b>Total Income</b></td> <td>₹ 289.3218 crs</td> <td>₹349.8322 crs</td> <td><img src="dist/img/Down.png" alt="Up Tick / Down Tick">-17.30%</td> </tr> <tr> <td><b>Net Profit</b></td> <td>₹72.0563 crs</td> <td>₹107.5421 crs</td> <td><img src="dist/img/Down.png" alt="Up Tick / Down Tick">-33.00%</td> </tr> <tr> <td><b>EPS</b></td> <td>₹2.83</td> <td>₹4.22</td> <td><img src="dist/img/Down.png" alt="Up Tick / Down Tick">-32.94%</td> </tr></table><br><b>Financial Results (Q2 FY2023) - YoY Comparison </b> <br><br>The company has reported total income of Rs. 289.3218 crores during the period ended September 30, 2022 as compared to Rs.306.0294 crores during the period ended September 30, 2021.<br><br>The company has posted net profit / (loss) of Rs.72.0563 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.96.9848 crores for the period ended September 30, 2021.<br><br>The company has reported EPS of Rs.2.83 for the period ended September 30, 2022 as compared to Rs.3.81 for the period ended September 30, 2021.<br><br><table width="100%" border="2" bordercolor="#789940" cellspacing="0" cellpadding="0"> <tr> <td class="newsheader"><b>Financials</b></td> <td class="newsheader"><b>Q2 FY2023</b></td> <td class="newsheader"><b>Q2 FY2022</b></td> <td class="newsheader"><b>% Change</td></b> </tr> <tr> <td><b>Total Income</b></td> <td>₹ 289.3218 crs</td> <td>₹306.0294 crs</td> <td><img src="dist/img/Down.png" alt="Up Tick / Down Tick">-5.46%</td> </tr> <tr> <td><b>Net Profit</b></td> <td>₹72.0563 crs</td> <td>₹96.9848 crs</td> <td><img src="dist/img/Down.png" alt="Up Tick / Down Tick">-25.70%</td> </tr> <tr> <td><b>EPS</b></td> <td>₹2.83</td> <td>₹3.81</td> <td><img src="dist/img/Down.png" alt="Up Tick / Down Tick">-25.72%</td> </tr> </table><br><b>Financial Results (Half Year Ended FY2023) - YoY Comparison </b> <br><br>The company has reported total income of Rs.639.1540 crores during the 6 Months period ended September 30, 2022 as compared to Rs.575.6136 crores during the 6 Months period ended September 30, 2021.<br><br>The company has posted net profit / (loss) of Rs.179.5984 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.202.0679 crores for the 6 Months period ended September 30, 2021.<br><br>The company has reported EPS of Rs.7.06 for the 6 Months period ended September 30, 2022 as compared to Rs.7.94 for the 6 Months period ended September 30, 2021.<br><br><table width="100%" border=2 bordercolor=#789940 cellspacing=0 cellpadding=0> <tr> <td class="newsheader"><b>Financials</b></td> <td class="newsheader"><b>Half Year Ended FY2023</b></td> <td class="newsheader"><b>Half Year Ended FY2022</b></td> <td class="newsheader"><b>% Change</b></td> </tr> <tr> <td><b>Total Income</b></td> <td>₹639.1540 crs</td> <td>₹575.6136 crs</td> <td><img src="dist/img/Up.png" alt="Up Tick / Down Tick">11.04%</td> </tr> <tr> <td><b>Net Profit</b></td> <td>₹179.5984 crs</td> <td>₹202.0679 crs</td> <td><img src="dist/img/Down.png" alt="Up Tick / Down Tick">-11.12%</td> </tr> <tr> <td><b>EPS</b></td> <td>₹7.06</td> <td>₹7.94</td> <td><img src="dist/img/Down.png" alt="Up Tick / Down Tick">-11.08%</td> </tr></table><br>Shares of Suven Pharmaceuticals Limited was last trading in BSE at Rs. 439.90 as compared to the previous close of Rs. 428.30. The total number of shares traded during the day was 48477 in over 2613 trades.<br><br>The stock hit an intraday high of Rs. 445.00 and intraday low of 426.00. The net turnover during the day was Rs. 21152306.00.</p> <p></p> <b></b> <b></b> <b></b> <b></b> <b></b> </div>
| ver. 1.4 |
Github
|
.
| PHP 8.2.9 | Generation time: 0.02 |
proxy
|
phpinfo
|
Settings